Trial intelligence / Profile preview

Nicotine mouth strip vs lozenge and gum for acute craving

NCT01476202Phase 2Completed

Sponsor
GSK
Start
Nov 2011
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by GSK. Started Nov 2011; status: completed.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT01476202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01476202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call